Ancora Innovation Overview

  • Founded
  • 2018
  • Status
  • Private
  • Latest Deal Type
  • Early Stage VC
  • Latest Deal Amount
  • $65M
Latest Deal Amount
  • Investors
  • 1

Ancora Innovation General Information


Developer of life science drugs intended to establish novel therapeutics. The company's research will accelerate the stage of the art drug development, enabling scientists to execute novel and potentially transformative research projects.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Primary Office
  • 780 Third Avenue
  • 37th Floor
  • New York, NY 10017
  • United States
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Ancora Innovation Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC 06-Apr-2018 $65M 0000 Completed Startup
To view Ancora Innovation’s complete valuation and funding history, request access »

Ancora Innovation Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Deerfield Management Venture Capital Minority 000 0000 000000 0
To view Ancora Innovation’s complete investors history, request access »